Physician profile
Daniel Dicesare
NPI 1528020245
$1,734.54
in general payments reported to CMS, 2019-2025
7 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.30 · 2022: $1,307 · 2023: $68.02 · 2024: $135 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380 · Education: $19.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.61 |
| Education | $19.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolase, INC. | $1,266.96 | 2022 | |
| Dentsply Sirona INC | $273.14 | 2021-2025 | Waveone Gold Conform Fit, Tph Spectra Universal Composite Restorative Low Viscosity, Sirolaser Advance |
| Zimvie INC. | $88.50 | 2024-2025 | |
| Align Technology, INC. | $38.58 | 2024 | Invisalign |
| Hu-Friedy Mfg. Co., LLC | $30.29 | 2024 | |
| Colgate Oral Pharmaceuticals, INC. | $19.67 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $17.40 | 2025 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dicesare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.